Literature DB >> 22921954

Familial aggregation of idiopathic normal pressure hydrocephalus: novel familial case and a family study of the NPH triad in an iNPH patient cohort.

Alexander McGirr1, Michael D Cusimano.   

Abstract

OBJECTIVE: Idiopathic normal pressure hydrocephalus (iNPH) is considered sporadic, yet familial cases involving single pedigrees are being increasingly recognized. As current evidence does not extend beyond isolated pedigrees, we aimed to determine the putative heritability of iNPH by examining the prevalence of the iNPH triad among the family members of iNPH probands.
METHOD: We present a case-control family study of the iNPH symptom triad among the relatives of iNPH patients (n=20) identified from a cohort of patients undergoing CSF diversion and matched comparison subjects (n=21). A total of 291 first-degree relatives from 41 families were characterized using semi-structured family history interviews. Independent from the family study, we present a novel well-characterized familial case of iNPH.
RESULTS: ≥ 2 insidious, progressive and idiopathic iNPH symptoms were identified among first degree relatives in 6 iNPH pedigrees (2 multiply affected) and 1 control pedigree, with an incidence of 7.1% among iNPH relatives and 0.7% among control relatives (OR=11.53). Gait disturbance and memory impairment began at a younger age among the relatives of iNPH probands. Independent of our family study, we present a novel case report of a large iNPH pedigree with multiple affected relatives.
INTERPRETATION: Our family study and novel familial case suggest familial aggregation of iNPH. A larger family study with full characterization of affected and unaffected relatives is warranted. Confirmation of heritability may allow identification of individuals at high-risk for iNPH, early intervention, and improved aetiological elucidation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22921954     DOI: 10.1016/j.jns.2012.07.062

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

2.  Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.

Authors:  Okko T Pyykkö; Miikka Lumela; Jaana Rummukainen; Ossi Nerg; Toni T Seppälä; Sanna-Kaisa Herukka; Anne M Koivisto; Irina Alafuzoff; Lakshman Puli; Sakari Savolainen; Hilkka Soininen; Juha E Jääskeläinen; Mikko Hiltunen; Henrik Zetterberg; Ville Leinonen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

3.  A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control Study.

Authors:  Hidenori Sato; Yoshimi Takahashi; Luna Kimihira; Chifumi Iseki; Hajime Kato; Yuya Suzuki; Ryosuke Igari; Hiroyasu Sato; Shingo Koyama; Shigeki Arawaka; Toru Kawanami; Masakazu Miyajima; Naoyuki Samejima; Shinya Sato; Masahiro Kameda; Shinya Yamada; Daisuke Kita; Mitsunobu Kaijima; Isao Date; Yukihiko Sonoda; Takamasa Kayama; Nobumasa Kuwana; Hajime Arai; Takeo Kato
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

4.  Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH.

Authors:  Ville E Korhonen; Seppo Helisalmi; Aleksi Jokinen; Ilari Jokinen; Juha-Matti Lehtola; Minna Oinas; Kimmo Lönnrot; Cecilia Avellan; Anna Kotkansalo; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Antti Junkkari; Mikko Hiltunen; Hilkka Soininen; Mitja Kurki; Juha E Jääskeläinen; Anne M Koivisto; Hidenori Sato; Takeo Kato; Anne M Remes; Per Kristian Eide; Ville Leinonen
Journal:  Neurol Genet       Date:  2018-12-03

5.  Nonsense mutation in CFAP43 causes normal-pressure hydrocephalus with ciliary abnormalities.

Authors:  Yoshiro Morimoto; Shintaro Yoshida; Akira Kinoshita; Chisei Satoh; Hiroyuki Mishima; Naohiro Yamaguchi; Katsuya Matsuda; Miako Sakaguchi; Takeshi Tanaka; Yoshihiro Komohara; Akira Imamura; Hiroki Ozawa; Masahiro Nakashima; Naohiro Kurotaki; Tatsuya Kishino; Koh-Ichiro Yoshiura; Shinji Ono
Journal:  Neurology       Date:  2019-04-19       Impact factor: 9.910

6.  Deletions in CWH43 cause idiopathic normal pressure hydrocephalus.

Authors:  Hong Wei Yang; Semin Lee; Dejun Yang; Huijun Dai; Yan Zhang; Lei Han; Sijun Zhao; Shuo Zhang; Yan Ma; Marciana F Johnson; Anna K Rattray; Tatyana A Johnson; George Wang; Shaokuan Zheng; Rona S Carroll; Peter J Park; Mark D Johnson
Journal:  EMBO Mol Med       Date:  2021-01-18       Impact factor: 12.137

7.  Incidental findings of typical iNPH imaging signs in asymptomatic subjects with subclinical cognitive decline.

Authors:  Doortje C Engel; Lukas Pirpamer; Edith Hofer; Reinhold Schmidt; Cornelia Brendle
Journal:  Fluids Barriers CNS       Date:  2021-08-14

8.  Diabetes is associated with familial idiopathic normal pressure hydrocephalus: a case-control comparison with family members.

Authors:  Joel Räsänen; Joel Huovinen; Ville E Korhonen; Antti Junkkari; Sami Kastinen; Simo Komulainen; Minna Oinas; Cecilia Avellan; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Kimmo Lönnrot; Markus Perola; Anne M Koivisto; Anne M Remes; Hilkka Soininen; Mikko Hiltunen; Seppo Helisalmi; Mitja I Kurki; Juha E Jääskeläinen; Ville Leinonen
Journal:  Fluids Barriers CNS       Date:  2020-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.